UltraSight in Cardiac Critical Care
UltraSight’s Echo Stewardship System includes PVAD IQ, an FDA-cleared tool for bedside echocardiography in patients using microaxial flow pumps.
ultrasight.comCrawled Nov 15, 2026
UltraSight’s Echo Stewardship System includes PVAD IQ, an FDA-cleared tool for bedside echocardiography in patients using microaxial flow pumps.
In demanding critical care environments, patients supported by microaxial flow pumps require timely and reliable insight into pump function and positioning.
Six studies in collaboration with Mayo Clinic confirm the UltraSight Echosystem enables non-expert clinicians to deliver diagnostic-quality cardiac ultrasound
With new advancements in therapeutics there is a growing need for ongoing echocardiographic monitoring. This increased demand has created a disparity in
Listed below are the jurisdictions where UltraSight’s software is approved and the labeling for each jurisdiction.
Tablet Requirements
Findings confirm diagnostic echocardiographic exams can be performed by medical professionals without sonography experience by using UltraSight
Images acquired with AI guidance software deemed usable in 100 percent of cardiac patients
Technology developed through partnership to monitor astronaut's heart during 'Rakia' space mission
OnSight Wins TCT connect 2020 Shark Tank Innovation Competition
Digital Health company transforming ultrasound industry
UltraSight Selected to Conduct a Study Onboard the International Space Station
UltraSight was founded on a simple but powerful idea: to apply the power of geometrical deep learning to cardiac ultrasound and give the ability to scan
UltraSight provides support to existing customers via phone or email.
UltraSight is an AI-powered cardiac workflow company advancing access to high-quality cardiac ultrasound.The UltraSight EchoSystem brings together
Last Updated: April 11, 2024
UltraSight Inc. operates a website at www.ultrasight.com, including its subdomains.